Here are four things to know:
1. This is the full-scale launch of the FDA-cleared system follows a successful limited rollout.
2. More than 100 patient levels were treated via both minimally invasive and open TLIF approaches during the limited rollout.
3. The system is designed to offer controlled, atraumatic insertion through a 6-8 mm cannula, which aims to minimize nerve retraction and mitigate implant migration.
4. At the NASS meeting, Benvenue Medical will also accept the 2015 Spine Technology Award for the Luna system in the Minimally Invasive Spine and Thoracolumbar Care categories.
More articles on devices:
FDA approves Mobi-C disc labeling update; includes 5-year study data: 6 things to know
Exactech launches Acapella One Cervical Spacer System: 5 key points
Life Spine releases devices for expandable lateral interbody fusions: 4 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
